Shasun Pharma may cross Rs 200-210, says Ambareesh Baliga, Market Analyst.
Baliga told CNBC-TV18,"I have been bearish on the auto space for quite a while saying those numbers, which we have seen in the past close to 15-18 months cannot continue to eternity and we will see a slowdown and that is exactly what has happened. At least for the foreseeable future we will see that slowdown continuing and could be at least till November-December. So surely there will be pressure on the auto space."
He further added, "But I think best of the lot would be Mahindra and Mahindra, possibly Tata Motors but Tata Motors closer to about Rs 200-205. I think rest of the pack for the time being should wait a while longer."
"I have been recommending two or three stocks in the pharma space, again not those at the higher end, but stocks like Dishman and Shasun. In Dishman Pharma, I see levels of closer to about Rs 135-140. Shasun Pharma should soon cross levels of about Rs 200-210."
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.